| South End Community Health Center Inc | |
|
1601 Washington Street Boston MA 02118 | |
| (617) 425-2000 | |
| (617) 424-8725 |
| Full Name | South End Community Health Center Inc |
|---|---|
| Speciality | Clinic/Center |
| Location | 1601 Washington Street, Boston, Massachusetts |
| Authorized Official Name and Position | William Walczak (CHIEF EXECUTIVE OFFICER) |
| Authorized Official Contact | 6174252000 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| South End Community Health Center Inc 1601 Washington Street Boston MA 02118 Ph: (617) 425-2000 | South End Community Health Center Inc 1601 Washington Street Boston MA 02118 Ph: (617) 425-2000 |
| NPI Number | 1558310052 |
|---|---|
| Provider Enumeration Date | 05/10/2006 |
| Last Update Date | 04/29/2019 |
| Medicare PECOS PAC ID | 9537063722 |
|---|---|
| Medicare Enrollment ID | O20070822001521 |
News Archive
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it has initiated a new Phase III trial designed to evaluate the efficacy, tolerability and safety of pimavanserin as a treatment for patients with Parkinson's disease psychosis (PDP).
GE Healthcare today introduced MR-Touch, a visual palpation technology that uses low frequency sound waves in combination with MRI to measure tissue elasticity. For centuries, clinicians have evaluated tissue stiffness—the physical property of tissue most affected by disease—through palpation. Based on technology invented at Mayo Clinic (Rochester, MN) and licensed to GE Healthcare,
Mice lacking the protein retGC1, which is deficient in humans suffering Leber congenital amaurosis-1 (LCA1), a disorder that causes severe visual impairment beginning in infancy, received gene therapy to replace retGC1 and showed fully restored visual function that persisted for at least 6 months.
OvaGene Oncology Inc., a molecular diagnostics company specializing in the development and commercialization of personalized gene-based diagnostics for gynecologic cancer, announced today that the company has received Clinical Laboratory Improvement Act (CLIA) certification for their newly constructed state-of-the-art molecular diagnostics laboratory.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558310052 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
News Archive
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it has initiated a new Phase III trial designed to evaluate the efficacy, tolerability and safety of pimavanserin as a treatment for patients with Parkinson's disease psychosis (PDP).
GE Healthcare today introduced MR-Touch, a visual palpation technology that uses low frequency sound waves in combination with MRI to measure tissue elasticity. For centuries, clinicians have evaluated tissue stiffness—the physical property of tissue most affected by disease—through palpation. Based on technology invented at Mayo Clinic (Rochester, MN) and licensed to GE Healthcare,
Mice lacking the protein retGC1, which is deficient in humans suffering Leber congenital amaurosis-1 (LCA1), a disorder that causes severe visual impairment beginning in infancy, received gene therapy to replace retGC1 and showed fully restored visual function that persisted for at least 6 months.
OvaGene Oncology Inc., a molecular diagnostics company specializing in the development and commercialization of personalized gene-based diagnostics for gynecologic cancer, announced today that the company has received Clinical Laboratory Improvement Act (CLIA) certification for their newly constructed state-of-the-art molecular diagnostics laboratory.
› Verified 7 days ago
Rong J Guan, Md Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 30 Kneeland St Fl 5, Boston, MA 02111 Phone: 617-290-9881 Fax: 617-350-6555 | |
Fenway Health Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1340 Boylston St, Boston, MA 02215 Phone: 617-927-4880 | |
Robert H. Wu. Md, Pc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 65 Harrison Ave Ste 308, Boston, MA 02111 Phone: 617-338-9889 | |
Barbara Mcinnis House Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 780 Albany St, Boston, MA 02118 Phone: 857-654-1000 Fax: 857-654-1100 | |
Pratt Medical Group, Inc - Gastroenterology Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 800 Washington St, Box 1013, Boston, MA 02111 Phone: 617-636-5000 | |
Pjtrains Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 14 Newbury St Ste 4, Boston, MA 02116 Phone: 857-205-2759 | |
Mhg Physician Services - Michigan Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 500 Harrison Ave, Boston, MA 02118 Phone: 855-340-4663 |